Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Coeliac Plexus vs Splanchnic Nerve Neurolysis for Upper Abdominal Cancer Pain

Official title: Effect of Coeliac Plexus Versus Splanchnic Nerve Neurolysis in Pain Management With Upper Abdominal Malignancies

Run by Bangladesh Medical University · NCT07653906 · Data updated 2026-11-12

This study tests whether neurolytic splanchnic nerve block helps reduce pain better than neurolytic coeliac plexus block in adults with upper abdominal cancers.

More Upper Abdominal Malignancies trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment44 (estimated)
SponsorBangladesh Medical University
Academic / other
Locations1 site (Dhaka)
StatusRecruiting
StartedMay 1, 2026
Main results expectedOctober 30, 2026
Study endsJanuary 31, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT07653906 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with pancreatic, gastric, hepatic, or biliary cancers experiencing moderate to severe pain (VAS ≥5) and no contraindications to nerve blocks.

Probably not a fit

Patients with contraindications to nerve blocks, prior relevant nerve blocks, infections at the block site, or other conditions limiting benefit may see little or no pain relief.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with upper abdominal malignancies and significant pain are randomly assigned to receive either a neurolytic coeliac plexus block or a neurolytic splanchnic nerve block under fluoroscopic guidance. Pain and safety are tracked immediately after the procedure and at 7 days, 1 month, and 3 months, with quality of life also evaluated at baseline. The trial aims to compare pain relief and adverse effects between the two nerve-block approaches. Procedures involve image-guided needle placement and neurolytic alcohol injections, with standard pre-procedure labs and post-procedure monitoring. The study is conducted at Bangladesh Medical University in Dhaka.

Why it matters

Potential benefit: If successful, patients may experience better or safer pain relief from one block approach, improving comfort and quality of life.

How similar studies have gone: Previous nerve-block approaches have shown variable analgesic effects; this direct comparison explores relative benefit in upper abdominal cancer pain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient
* Both genders
* Diagnosed case of upper abdominal malignancy (pancreatic, gastric, hepatic, or biliary origin)
* Experiencing moderate to severe pain (≥5 on a 10 point visual analog scale)
* Patients who are conscious and can communicate
* No Contraindication for nerve block (e.g., coagulopathy, anticoagulant drugs)

Exclusion Criteria:

* Previous coeliac plexus block, splanchnic nerve block, or major abdominal nerve ablation
* Severe spinal deformities or anatomical distortion at the coeliac plexus or splanchnic nerve site
* Local or systemic infection at or near the block site
* Known allergy to local anesthetics or neurolytic agents
* Pregnancy
* Lactating mother
* Cognitive impairment or psychiatric illness

Where it's running

  • Bangladesh Medical University
    Dhaka, Bangladesh
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.